High Pointe Capital Management’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-22,770
Closed -$2.31M 81
2015
Q4
$2.31M Buy
22,770
+1,670
+8% +$188K 1.14% 24
2015
Q3
$3.76M Buy
21,100
+1,250
+6% +$291K 1.77% 7
2015
Q2
$4.41M Hold
19,850
1.58% 5
2015
Q1
$3.94M Buy
19,850
+7,270
+58% +$1.29M 1.41% 6
2014
Q4
$1.8M Buy
12,580
+2,730
+28% +$367K 0.79% 50
2014
Q3
$1.29M Sell
9,850
-8,750
-47% -$1.04M 0.56% 79
2014
Q2
$2.35M Hold
18,600
0.85% 43
2014
Q1
$2.45M Hold
18,600
0.95% 32
2013
Q4
$2.18M Sell
18,600
-4,750
-20% -$520K 0.86% 45
2013
Q3
$2.44M Sell
23,350
-450
-2% -$43.8K 0.98% 28
2013
Q2
$2.05M Buy
+23,800
New +$1.88M 0.9% 38

Other funds holding BHC

High Pointe Capital Management's BHC Position: Q1 2016 in Review

High Pointe Capital Management sold out of Bausch Health (BHC) in Q1 2016, closing a stake of 22,770 shares — an estimated $2.31M sold.

High Pointe Capital Management first reported a position in BHC in Q2 2013 and held it in 11 quarters. The position peaked at $4.41M in Q2 2015. 389 funds tracked by Wall St. Rank hold BHC as of Q1 2016.

  • High Pointe Capital Management reported no remaining Bausch Health position as of Q1 2016 after selling out during the quarter.
  • High Pointe Capital Management sold 22,770 Bausch Health shares in Q1 2016, an estimated $2.31M.
  • High Pointe Capital Management first reported a position in Bausch Health in Q2 2013 and held it in 11 quarters.
  • High Pointe Capital Management's Bausch Health position peaked at $4.41M in Q2 2015.
  • 389 funds tracked by Wall St. Rank held Bausch Health as of Q1 2016.

Based on High Pointe Capital Management's 13F filing for Q1 2016, filed 5 May 2016.